The MRI features of white matter and the absence of cortical gray matter findings substantially differentiate NMOSDs from MS and can be used as a potential marker to distinguish these 2 entities. The fact that cortical pathology is common in MS but is not present in patients with NMOSDs may reflect the difference in the underlying pathogenesis.
for the MAGNIMS Study Group IMPORTANCE The central vein sign has been proposed as a specific imaging biomarker for distinguishing between multiple sclerosis (MS) and not MS, mainly based on findings from ultrahigh-field magnetic resonance imaging (MRI) studies. The diagnostic value of the central vein sign in a multicenter setting with a variety of clinical 3 tesla (T) MRI protocols, however, remains unknown. OBJECTIVE To evaluate the sensitivity and specificity of various central vein sign lesion criteria for differentiating MS from non-MS conditions using 3T brain MRI with various commonly used pulse sequences. DESIGN, SETTING, AND PARTICIPANTS This large multicenter, cross-sectional study enrolled participants (n = 648) of ongoing observational studies and patients included in neuroimaging research databases of 8 neuroimaging centers in Europe. Patient enrollment and MRI data collection were performed between
At 7T MRI, plaques in MS patients and patients with Susac syndrome differed substantially with respect to morphology and pattern. Thus, lesion morphology at 7T (i) may serve as a marker to distinguish Susac syndrome from MS and (ii) reflects a different pathophysiological mechanism underlying Susac syndrome, for example microinfarction rather than demyelination.
• Focal destruction of the optic radiation is detectable by 7 T MRI. • Focal optic radiation damage is common in MS. • Optic radiation damage is associated with RNFL thinning, detectable by OCT. • Optic radiation damage is associated with delayed VEP and visual dysfunction. • RNFL thickness in non-optic neuritis eyes correlates with optic radiation demyelination.
Background and Purpose
To investigate the potential of ultra-high field MR imaging to distinguish multiple sclerosis (MS) from neuromyelitis optica (NMO) and to characterize tissue injury associated with iron pathology within lesions.
Methods
Twenty-one MS and 21 NMO patients underwent 7T high-resolution 2D-gradient-echo (GRE-T2*) and 3D-susceptibility weighted imaging (SWI). An in-house developed algorithm was used to reconstruct quantitative susceptibility mapping (QSM) from SWI. Lesions were classified as ‘iron laden’ if they demonstrated hypointensity on GRE-T2*- weighted images and/or SWI, and hyperintensity on QSM. Lesions were considered ‘non-iron laden’ if they were hyperintense on GRE-T2* and isointense or hyperintense on QSM.
Results
Of 21 MS patients, 19 (90.5%) demonstrated atleast one QSM-hyperintense lesion and 11/21 (52.4%) patients harbored iron-laden lesions. No QSM-hyperintense or iron-laden lesions were observed in any of the NMO patients. Iron-laden and non iron-laden lesions could each be further characterized into two distinct patterns based on lesion signal and morphology on GRE-T2*/SWI and QSM. In MS, the majority of lesions (n=262, 75.9% of all lesions) were hyperintense on GRE-T2* and isointense on QSM (Pattern A), while a small minority (n=26, 7.5% of all lesions) were hyperintense on both GRE-T2* and QSM (Pattern B). Iron laden lesions (n=57, 16.5% of all lesions) were further classified as ‘nodular’ (n=22, 6.4%, Pattern C) or ‘ring-like’ (n=35, 10.1%, Pattern D).
Conclusions
Ultra-high field MRI may be useful in distinguishing MS from NMO. Different patterns related to iron and non-iron pathology may provide in vivo insights into pathophysiology of lesions in MS.
Background: Brain lesions with a hypointense ring or core were described in multiple sclerosis on susceptibility weighted imaging. Objective: The purpose of this study was to study the evolution and prognostic relevance of susceptibility weighted imaging hypointense lesions in clinically isolated syndrome and early multiple sclerosis. Methods: Sixty-six early multiple sclerosis and clinically isolated syndrome patients were followed over a median period of 2.9 years (range 1.6-4.6 years) and underwent 3T magnetic resonance imaging including 3D susceptibility weighted imaging and T2-weighted fluid-attenuated inversion recovery. We assessed the presence of susceptibility weighted imaging hypointense core or ring lesions, and Expanded Disability Status Scale at baseline and follow-up. Results: Of 611 lesions at baseline, 64 (10.5%) had a susceptibility weighted imaging hypointense core, and 28 (4.6%) had a susceptibility weighted imaging hypointense ring. Hypointense ring lesions were larger (p < 0.001) and more T1w hypointense (p ¼ 0.002) than others. During follow-up, hypointense core lesions became susceptibility weighted imaging isointense (52 lesions, 81%); few developed into hypointense ring lesions (two lesions, 3%). Hypointense ring lesions did not shrink on T2-weighted fluid-attenuated inversion recovery images (p ¼ 0.077, trend towards more enlargement compared to others), while hypointense core lesions more often shrunk in comparison to lesions without a hypointense core (p ¼ 0.002). The number of susceptibility weighted imaging hypointense ring lesions at baseline correlated with Expanded Disability Status Scale progression at follow-up (p ¼ 0.021, R ¼ 0.289). Conclusion: In our cohort of patients with clinically isolated syndrome or early multiple sclerosis, susceptibility weighted imaging hypointense ring lesions were only rarely detectable, but did not shrink and were associated with future disability progression.
High spatially resolving anatomical T2*-weighted MRI revealed vascular alterations in early stages of multiple sclerosis, presumably as a part of widespread haemodynamic and metabolic alterations.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.